Supplements for Longevity & Their Efficacy | Dr. Peter Attia

概览

Andrew Huberman and Dr. Peter Attia examine whether boosting the NAD pathway through NAD infusions, NR, or NMN has credible evidence for improving healthspan or lifespan. The central conclusion is cautious: NAD biology is important, but the leap from “NAD participates in essential cellular processes” to “supplementing NAD precursors extends human life” is not supported by the evidence discussed.

The conversation builds from a broader framework for longevity: behaviors, disease-targeting drugs, and geroprotective molecules. Attia repeatedly distinguishes mechanistic plausibility from experimental proof, using rapamycin and the Interventions Testing Program as examples of a higher evidence bar.

The episode also covers sirtuins, caloric restriction, resveratrol, human NR/NMN studies, biological age testing, radiation concerns, exercise timing, and the hosts’ own supplement routines. Both end by emphasizing that sleep, exercise, nutrition, and emotional health matter far more than any supplement discussed.

分段落总结

[00:00] Episode Scope

[事实] Huberman introduces Peter Attia as a physician focused on healthspan and lifespan.

[事实] The stated topic is the NAD pathway, including NAD, NR, NMN, delivery routes, and whether these approaches affect longevity or healthspan.

[事实] Huberman says they will also discuss rapamycin, metformin, fasting, and their own supplement regimens.

[06:43] Frameworks for Longevity

[事实] Huberman proposes categories including behavioral “do’s and don’ts,” calorie/glucose/insulin/mTOR-related approaches, NAD-pathway targeting, and more aggressive “kitchen sink” longevity strategies.

[事实] Attia reframes the categories as essential behaviors, molecules that target disease processes, and molecules that target hallmarks or pathways of aging.

[事实] Attia says modern lifespan extension largely means delaying chronic diseases such as cardiovascular disease, cancer, neurodegenerative disease, dementing disease, and metabolic disease.

[推测] The discussion sets up NAD supplements as one small candidate inside a much larger longevity strategy, not as the foundation.

[17:22] Rapamycin and Evidence Standards

[事实] Attia says he takes a PCSK9 inhibitor, bempedoic acid, an SGLT2 inhibitor, and rapamycin.

[事实] He takes rapamycin at eight milligrams once weekly when tolerated, but often pauses because he gets canker sores.

[事实] Attia’s confidence in rapamycin comes less from mechanism alone and more from experimental data across organisms.

[事实] He says caloric restriction and rapamycin are the only two interventions discussed that have extended life across yeast, worms, flies, and mammals.

[25:01] NAD Biology

[事实] NAD is described as one of the body’s most ubiquitous molecules and is associated with energy production and mitochondrial pathways.

[事实] Attia says most NAD functions as a cofactor, shuttling electrons between NAD and NADH without being consumed.

[事实] A smaller portion of NAD is consumed as a substrate by sirtuins, which are discussed in relation to DNA repair.

[事实] NAD levels are described as tightly regulated, similar in principle to glucose or pH.

[32:07] Sirtuins and Caloric Restriction

[事实] Attia describes yeast studies where sirtuin overexpression extended lifespan in some strains.

[事实] He says later work suggested sirtuin overexpression and caloric restriction act through independent, additive pathways rather than the same pathway.

[事实] A 2012 transgenic mouse study overexpressing SIRT6 increased lifespan in male mice but not female mice.

[推测] The sirtuin evidence is treated as biologically interesting but too indirect to justify strong human longevity claims.

[43:42] Sirtuin Effects and DNA Repair

[事实] Attia says activated sirtuins are believed to improve mitochondrial biogenesis, increase DNA repair, and reduce soluble products of senescent cells.

[事实] The conversation links aging to accumulating DNA damage, reduced repair capacity, and declining immune detection.

[事实] Attia explains the logic behind NAD supplementation: if sirtuins need NAD for DNA repair and NAD declines with age, raising NAD might seem helpful.

[推测] This is presented as a plausible chain of reasoning, but not as proof that supplementation improves lifespan.

[49:16] Resveratrol as a Warning Case

[事实] Resveratrol is discussed as a famous proposed sirtuin activator found in trace amounts in grape skin and wine.

[事实] Attia says one mouse study showed benefit in a severe high-fat-diet model with massive fatty liver, but that model was unusual.

[事实] He says the Interventions Testing Program later found no lifespan benefit from resveratrol.

[推测] The resveratrol story functions as a caution against turning mechanistic appeal into broad human claims.

[55:06] NAD Decline and Redox Potential

[事实] Attia says NAD declines with age in many tissues, with skin showing around a 60% reduction and blood or brain closer to 15-20%.

[事实] He cites a human blood study in which NAD declined while NADH rose, suggesting total NAD plus NADH may not be the main issue.

[事实] He argues the aging issue may be reduced redox potential and declining mitochondrial function rather than simply “not enough NAD.”

[事实] Huberman connects this to work on red light and near-infrared light in aged eyes, discussed as potentially affecting reactive oxygen species and mitochondrial function.

[62:14] NR, NMN, and NAD Delivery

[事实] The hosts describe three common approaches: intravenous NAD, oral NR, and oral or sublingual NMN.

[事实] Attia says NR crosses cell membranes easily, while NMN has a phosphate group that must be removed.

[事实] Huberman says he has tried NAD infusions and found the first part uncomfortable, with chest pressure, leg cramps, nausea, and irritability.

[事实] Huberman reports taking sublingual NMN at about 1.5 grams and noticing faster hair and nail growth plus some increase in energy.

[74:00] ITP Evidence on Longevity

[事实] Attia describes the Interventions Testing Program as the most rigorous non-human tool for testing lifespan interventions.

[事实] He says NR was tested at a robust dose and did not extend lifespan or improve healthspan in that program.

[事实] Rapamycin, canagliflozin, acarbose, and 17-alpha estradiol are cited as interventions with positive ITP results.

[事实] Canagliflozin and acarbose are discussed as glucose-regulating interventions that worked without making the mice lighter.

[78:10] Human NR and NMN Studies

[事实] Attia discusses a human study of NR plus pterostilbene in fatty liver disease where the primary outcomes showed no difference.

[事实] A subgroup analysis showed liver fat reduction in a lower-dose group below a certain baseline hepatic fat threshold, but not in the full-dose group.

[事实] He also describes an NMN glucose-disposal study that showed a statistically significant but clinically small improvement under insulin infusion.

[推测] The human data are portrayed as suggestive at best and insufficient for strong clinical or longevity claims.

[85:38] Commercial and Regulatory Context

[事实] Huberman says the FDA had indicated NMN should not be sold as a supplement, although it remained available online.

[事实] NR is described as generally recognized as safe and available as a supplement.

[事实] Attia characterizes the NMN-versus-NR debate as largely commercial rather than scientifically decisive.

[事实] The hosts say raising NAD in blood or liver does not establish meaningful effects in skeletal muscle or other target tissues.

[87:47] Possible Skin Cancer Signal

[事实] Attia identifies one potentially genuine benefit signal: a study suggesting a 60-80% reduction in basal cell and squamous cell carcinomas.

[事实] He notes the study did not show a reduction in melanoma.

[事实] The hosts connect this cautiously to the fact that skin appears to show the largest age-related NAD decline.

[推测] For people at high risk of basal or squamous cell carcinoma, repeated positive findings could make NR or NMN more relevant.

[104:37] Biological Age Tests and Radiation

[事实] Attia is skeptical of biological aging tests and says chronological age often remains a stronger practical predictor of remaining lifespan.

[事实] He argues many biological age measurements contain noise, especially when based on biomarkers that vary with context.

[事实] He also says he does not avoid airport scanners or worry much about flight-related radiation based on the radiation levels discussed.

[推测] The broader point is that longevity tracking tools can distract from more meaningful behaviors if users overinterpret precision.

[118:47] Physiological Reserve and Energy

[事实] Attia says the work done in midlife helps set the stage for preserving vitality in later decades.

[事实] He emphasizes building or maintaining muscle mass, strength, and power before these become much harder to regain.

[事实] Huberman asks why energy declines with age, and Attia says he does not think anyone has fully answered that question.

[事实] Both agree that sleep, exercise, and nutrition likely matter far more for vitality than NAD supplements.

[127:17] Exercise Timing and Daily Vigor

[事实] Huberman says completing workouts before 9 a.m. tends to give him more energy across the day than later workouts.

[事实] Attia raises the possibility of reverse causality: high-energy people may simply be more likely to exercise early.

[事实] Huberman suggests people experiment with exercise timing and observe how it affects energy and focus.

[推测] The discussion treats exercise timing as an underexplored variable in healthspan and daily performance.

[131:56] Supplement Regimens and Final Verdict

[事实] Attia says he does not take NR, NMN, or NAD, while Huberman takes NR and NMN without strict adherence.

[事实] Attia lists supplements including EPA/DHA, Theracumin, vitamin D, methyl folate, methyl B12, magnesium forms, ashwagandha, electrolytes, creatine, AG1, and Pendulum probiotics.

[事实] Huberman lists AG1, fish oil, vitamin D3, methyl B12, Tongkat Ali, green tea capsules, yerba mate, NMN, sometimes NR, electrolytes, creatine, sleep supplements, whey protein, and occasional other compounds.

[事实] Both conclude that NAD, NR, and NMN should not currently be viewed as a lifespan-extension strategy.

[144:40] Supplements in Perspective

[事实] Huberman says supplements are optional and may serve as insurance or augmentation, but are not necessary.

[事实] Attia says exercise, sleep, nutrition, and emotional health are vastly more important than the supplements discussed.

[事实] Huberman and Attia both answer “no” to focusing on NAD supplementation or infusions for extending life.

[事实] Attia says he is willing to change his mind if new data emerge, but currently has no plan to take these supplements.

播客点评/总结

[推测] This episode’s value is its careful separation of mechanism, animal evidence, human biomarkers, and actual lifespan claims. The discussion is especially useful for listeners who have heard strong marketing around NAD, NR, or NMN and want a more skeptical evidence framework.

[推测] The strongest feature is Attia’s insistence on experimental rigor: rapamycin, ITP results, and failed resveratrol claims are used to show why plausible biology is not enough. Huberman adds practical self-observations, but repeatedly distinguishes them from proof of longevity benefit.

[推测] The main limitation is that several topics are discussed through memory of studies rather than full paper-by-paper review in the transcript. The episode is best treated as a high-level expert conversation, not as medical advice or a complete systematic review.

[推测] It is best suited for listeners interested in longevity science, supplement claims, and how to think about evidence. People looking for a simple supplement protocol may find the conclusion unsatisfying, because the practical answer is mostly to prioritize exercise, sleep, nutrition, and emotional health over NAD-pathway products.